Antidiabetic activity of Embelia ribes, embelin and its derivatives: A systematic review and meta-analysis

Biomedicine and Pharmacotherapy

Volumn 86, Issue , 2017, Pages 195-204

  Durg, Sharanbasappa ^a   Veerapur, Veeresh P ^b   Neelima, Satrasala ^c   Dhadde, Shivsharan B ^d  

^a Independent Researcher   (India)

^b SREE SIDDAGANGA COLLEGE OF PHARMACY   (India)

^c Vasavi Institute of Pharmaceutical Sciences   (India)

^d DSTS M's College of Pharmacy   (India)

Author keywords

Alloxan monohydrate; Blood glucose; Embelia ribes; Insulin; Meta analysis; Streptozotocin

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CHOLESTEROL; CREATININE; EMBELIN; FATTY ACID; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HEXOKINASE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ANTIDIABETIC AGENT; PLANT EXTRACT;

ANTIDIABETIC ACTIVITY; BERRY; BIOCHEMICAL ANALYSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; EMBELIA RIBES; ENZYME ACTIVITY; FRUIT; GLUCOSE BLOOD LEVEL; HEMODYNAMIC PARAMETERS; HUMAN; HYDROGEN BOND; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; META ANALYSIS; MOLECULAR DOCKING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANIMAL; DRUG EFFECTS; EMBELIA; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY;

ANIMALS; DIABETES MELLITUS; EMBELIA; HUMANS; HYPOGLYCEMIC AGENTS; OXIDATIVE STRESS; PLANT EXTRACTS;

EID: 85003815217     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.12.001     Document Type: Review

References (33)

1. [1] Guhabakshi, D.N., Sensarma, P., Pal, D.C., Lexicon, A., Medicinal Plants of India. 2001, Naya Prakashan, Calcutta, India, 135.
2. [2] Mahendran, S., Badami, S., Maithili, V., Evaluation of antidiabetic effect of embelin from Embelia ribes in alloxan induced diabetes in rats. Biomed. Pharmacother. 1 (2010), 25–31.
3. [3] Tripathi, S.N., Screening of hypoglycemic action in certain indigenous drugs. J. Indian Med. Yoga Homeopath. 14 (1979), 159–169.
4. [4] Bhandari, U., Kanojia, R., Pillai, K.K., Effect of ethanolic extract of Embelia ribes on dyslipidemia in diabetic rats. Int. J. Exp. Diabetes Res. 3 (2002), 159–162.
5. [5] Bhandari, U., Jain, N., Pillai, K.K., Further studies on antioxidant potential and protection of pancreatic beta-cells by Embelia ribes in experimental diabetes. Exp. Diabetes Res., 2007, 2007, 15803.
6. [6] Bhandari, U., Jain, N., Ansari, M.N., Pillai, K.K., Beneficial effect of Embelia ribes ethanolic extract on blood pressure and glycosylated hemoglobin in streptozotocin-induced diabetes in rats. Fitoterapia 79 (2008), 351–355.
7. [7] Bhandari, U., Ansari, M.N., Antihyperglycaemic activity of aqueous extract of Embelia ribes Burm in streptozotocin-induced diabetic rats. Indian J. Exp. Biol. 46 (2008), 607–613.
8. [8] Bhandari, U., Ansari, M.N., Ameliorative effect of an ethanol extract of Embelia ribes fruits on isoproterenol-induced cardiotoxicity in diabetic rats. Pharm. Biol. 47 (2009), 669–674.
9. [9] Purohit, A., Vyas, K.B., Vyas, S.K., Hypoglycaemic activity of Embelia ribes berries (50% etoh) extract in alloxan induced diabetic rats. Anc. Sci. Life 27 (2008), 41–44.
10. [10] Gupta, R., Sharma, A.K., Sharma, M.C., Gupta, R.S., Antioxidant activity and protection of pancreatic β-cells by embelin in streptozotocin-induced diabetes. J. Diabetes 4 (2012), 248–256.
11. [11] Bhandari, U., Chaudhari, H.S., Khanna, G., Najmi, A.K., Antidiabetic effects of Embelia ribes extract in high fat diet and low dose streptozotocin-induced type 2 diabetic rats. Front. Life Sci. 7 (2013), 186–196.
12. [12] Chaudhari, H.S., Bhandari, U., Khanna, G., Embelia ribes extract reduces high fat diet and low dose streptozotocin-induced diabetic nephrotoxicity in rats. EXCLI J. 12 (2013), 858–871.
13. [13] Gandhi, G.R., Stalin, A., Balakrishna, K., Ignacimuthu, S., Paulraj, M.G., Vishal, R., Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3 K/p-Akt signaling pathway by embelin in type 2 diabetic rats. Biochim. Biophys. Acta 1830 (2013), 2243–2255.
14. [14] Naik, S.R., Niture, N.T., Ansari, A.A., Shah, P.D., Anti-diabetic activity of embelin: involvement of cellular inflammatory mediators, oxidative stress and other biomarkers. Phytomedicine 20 (2013), 797–804.
15. [15] Stalin, A., Irudayaraj, S.S., Gandhi, G.R., Balakrishna, K., Ignacimuthu, S., Al-Dhabi, N.A., Hypoglycemic activity of 6-bromoembelin and vilangin in high-fat diet fed-streptozotocin-induced type 2 diabetic rats and molecular docking studies. Life Sci. 153 (2016), 100–117.
16. [16] Atal, C.K., Siddiqui, M.A., Zutshi, U., Amla, V., Johri, R.K., Rao, P.G., Kour, S., Non-narcotic orally effective, centrally acting analgesic from an ayurvedic drug. J. Ethnopharmacol. 11 (1984), 309–317.
17. [17] Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med., 6, 2009, e1000100.
18. [18] Durg, S., Dhadde, S.B., Vandal, R., Shivakumar, B.S., Charan, C.S., Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis. J. Pharm. Pharmacol. 67 (2015), 879–899.
19. [19] Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
20. [20] Vesterinen, H.M., Sena, E.S., Egan, K.J., Hirst, T.C., Churolov, L., Currie, G.L., Antonic, A., Howells, D.W., Macleod, M.R., Meta-analysis of data from animal studies: a practical guide. J. Neurosci. Methods 221 (2014), 92–102.
21. [21] Hooijmans, C.R., Rovers, M.M., de Vries, R.B., Leenaars, M., Ritskes-Hoitinga, M., Langendam, M.W., SYRCLE's risk of bias tool for animal studies. BMC Med. Res. Methodol., 14, 2014, 43.
22. [22] Zeng, X., Zhang, Y., Kwong, J.S., Zhang, C., Li, S., Sun, F., Niu, Y., Du, L., The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J. Evid. Based Med. 8 (2015), 2–10.
23. [23] Lenzen, S., The mechanism of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 (2008), 216–226.
24. [24] Szkudelski, T., The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiol. Res. 50 (2001), 536–546.
25. [25] Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L., Ramarao, P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52 (2005), 313–320.
26. [26] Petersen, K.F., Shulman, G.I., Etiology of insulin resistance. Am. J. Med. 119 (2006), 10–16.
27. [27] Wagner, A.M., Martijnez-Rubio, A., Ordonez-Llanos, J., Ordonez-Llanos, J., Perez-Perez, A., Diabetes mellitus and cardiovascular disease. Eur. J. Intern. Med. 13 (2002), 15–30.
28. [28] Almdal, T.P., Vilstrup, H., Strict insulin treatment normalizes the organic nitrogen contents and the capacity of urea-N synthesis in experimental diabetes in rats. Diabetologia 31 (1988), 114–118.
29. [29] Navarro, C.M., Montilla, P.M., Martin, A., Jiménez, J., Pilar Utrilla, M., Free radicals scavenger and antihepatotoxic activity of Rosmarinus. Planta Med. 59 (1993), 312–314.
30. 12 supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats. Pharmacol. Res. 46 (2002), 213–219.
31. [31] Lee, Y.S., Cha, B.Y., Saito, K., Yamakawa, H., Choi, S.S., Yamaguchi, K., Yonezawa, T., Teruya, T., Nagai, K., Woo, J.T., Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochem. Pharmacol. 79 (2010), 1674–1683.
32. [32] Chavez, E., Henry, R.R., Type 2 diabetes: insulin resistance, beta cell dysfunction, and other metabolic and hormonal abnormalities. Fonseca, V.A., (eds.) Clinical Diabetes: Translating Research into Practice, 2005, WB Saunders Co, USA, 21–35.
33. [33] Onkaramurthy, M., Veerapur, V.P., Thippeswamy, B.S., Reddy, T.N., Rayappa, H., Badami, S., Anti-diabetic and anti-cataract effects of Chromolaena odorata Linn., in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 145 (2013), 363–372.